Actinium Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Actinium Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Actinium Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $153K, a 2% increase year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $606K, a 72.2% increase from 2022.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $352K, a 6.63% decline from 2021.
  • Actinium Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $377K, a 0.53% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $153K +$3K +2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q1 2023 $150K +$56K +59.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q1 2022 $94K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $94K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2020 $94K +$8K +9.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q2 2019 $85.9K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $86K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.